Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2013

Feb 28, 2013

30403_dirs_2013-02-28_f4fd2d45-a2d2-4573-9b41-0b1d3ee2cb37.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2013-02-26

Reporting Person: DELKER WAYNE L (SVP-Chief Innovation Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-26 Common Stock M 1248.0000 $57.0000 Acquired 16130.0000 Direct
2013-02-26 Common Stock S 1192.0000 $83.7568 Disposed 14938.0000 Direct
2013-02-27 Common Stock M 11652.0000 $57.0000 Acquired 26590.0000 Direct
2013-02-27 Common Stock S 11131.0000 $83.8863 Disposed 15459.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-26 Stock Option (Right to Buy) $57.0000 M 1248.0000 Disposed 2015-09-21 Common Stock (1248.0000) Direct
2013-02-27 Stock Option (Right to Buy) $57.0000 M 11652.0000 Disposed 2015-09-21 Common Stock (11652.0000) Direct

Footnotes

F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: This transaction was executed in multiple trades at prices ranging from $83.7500 to $83.7800. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $83.7500 to $84.0865. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.